Randomized Trial of Near-infrared Incisionless Fluorescent Cholangiography.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 8 1 2019
medline: 21 3 2020
entrez: 8 1 2019
Statut: ppublish

Résumé

Incisionless near-infrared fluorescent cholangiography (NIFC) is emerging as a promising tool to enhance the visualization of extrahepatic biliary structures during laparoscopic cholecystectomies. We conducted a single-blind, randomized, 2-arm trial comparing the efficacy of NIFC (n = 321) versus white light (WL) alone (n = 318) during laparoscopic cholecystectomy. Using the KARL STORZ Image1 S imaging system with OPAL1 technology for NIR/ICG imaging, we evaluated the detection rate for 7 biliary structures-cystic duct (CD), right hepatic duct (RHD), common hepatic duct, common bile duct, cystic common bile duct junction, cystic gallbladder junction (CGJ), and accessory ducts -before and after surgical dissection. Secondary calculations included multivariable analysis for predictors of structure visualization and comparing intergroup biliary duct injury rates. Predissection detection rates were significantly superior in the NIFC group for all 7 biliary structures, ranging from 9.1% versus 2.9% to 66.6% versus 36.6% for the RHD and CD, respectively, with odds ratios ranging from 2.3 (95% CI 1.6-3.2) for the CGJ to 3.6 (1.6-9.3) for the RHD. After dissection, similar intergroup differences were observed for all structures except CD and CGJ, for which no differences were observed. Significant odds ratios ranged from 2.4 (1.7-3.5) for the common hepatic duct to 3.3 (1.3-10.4) for accessory ducts. Increased body mass index was associated with reduced detection of most structures in both groups, especially before dissection. Only 2 patients, both in the WL group, sustained a biliary duct injury. In a randomized controlled trial, NIFC was statistically superior to WL alone visualizing extrahepatic biliary structures during laparoscopic cholecystectomy. NCT02702843.

Sections du résumé

BACKGROUND
Incisionless near-infrared fluorescent cholangiography (NIFC) is emerging as a promising tool to enhance the visualization of extrahepatic biliary structures during laparoscopic cholecystectomies.
METHODS
We conducted a single-blind, randomized, 2-arm trial comparing the efficacy of NIFC (n = 321) versus white light (WL) alone (n = 318) during laparoscopic cholecystectomy. Using the KARL STORZ Image1 S imaging system with OPAL1 technology for NIR/ICG imaging, we evaluated the detection rate for 7 biliary structures-cystic duct (CD), right hepatic duct (RHD), common hepatic duct, common bile duct, cystic common bile duct junction, cystic gallbladder junction (CGJ), and accessory ducts -before and after surgical dissection. Secondary calculations included multivariable analysis for predictors of structure visualization and comparing intergroup biliary duct injury rates.
RESULTS
Predissection detection rates were significantly superior in the NIFC group for all 7 biliary structures, ranging from 9.1% versus 2.9% to 66.6% versus 36.6% for the RHD and CD, respectively, with odds ratios ranging from 2.3 (95% CI 1.6-3.2) for the CGJ to 3.6 (1.6-9.3) for the RHD. After dissection, similar intergroup differences were observed for all structures except CD and CGJ, for which no differences were observed. Significant odds ratios ranged from 2.4 (1.7-3.5) for the common hepatic duct to 3.3 (1.3-10.4) for accessory ducts. Increased body mass index was associated with reduced detection of most structures in both groups, especially before dissection. Only 2 patients, both in the WL group, sustained a biliary duct injury.
CONCLUSIONS
In a randomized controlled trial, NIFC was statistically superior to WL alone visualizing extrahepatic biliary structures during laparoscopic cholecystectomy.
REGISTRATION NUMBER
NCT02702843.

Identifiants

pubmed: 30614881
doi: 10.1097/SLA.0000000000003178
doi:

Substances chimiques

Fluorescent Dyes 0
Indocyanine Green IX6J1063HV

Banques de données

ClinicalTrials.gov
['NCT02702843']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

992-999

Auteurs

Fernando Dip (F)

Department of Surgery, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.
Department of General Surgery, Cleveland Clinic Florida, Weston, FL.

Emanuelle LoMenzo (E)

Department of Surgery, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.

Luis Sarotto (L)

Department of Surgery, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.

Edward Phillips (E)

Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

Hernan Todeschini (H)

Department of Surgery, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.

Mario Nahmod (M)

Department of Surgery, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.

Lisandro Alle (L)

Department of Surgery, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.

Sylke Schneider (S)

Department of Surgery, Klinikum Südstadt Südring 81, Rostock, Germany.

Ludwig Kaja (L)

Department of Surgery, Klinikum Südstadt Südring 81, Rostock, Germany.

Luigi Boni (L)

General and Emergency Surgery IRCCS-Ca' Granda-Policlinico Hospital, University of Milan|UNIMI, Milan, Italy.

Pedro Ferraina (P)

Department of Surgery, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.

Thomas Carus (T)

Department of Surgery, Asklepios Westklinikum Suurheid 20, Hamburg, Germany.

Norihiro Kokudo (N)

Faculty of Medicine University Hospital, Artificial Organ and Transplantation Surgery, University of Tokyo, Tokyo, Japan.

Takeaki Ishizawa (T)

Faculty of Medicine University Hospital, Artificial Organ and Transplantation Surgery, University of Tokyo, Tokyo, Japan.

Mathew Walsh (M)

Cleveland Clinic, Cleveland, OH.

Conrad Simpfendorfer (C)

Department of General Surgery, Cleveland Clinic Florida, Weston, FL.

Roy Mayank (R)

Department of General Surgery, Cleveland Clinic Florida, Weston, FL.

Kevin White (K)

ScienceRight Editing and Publishing, London, ON, Canada.

Raul J Rosenthal (RJ)

Department of General Surgery, Cleveland Clinic Florida, Weston, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH